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Developing strategies to maintain cognitive health is critical to quality of life during
aging. The basis of healthy cognitive aging is poorly understood; thus, it is difficult
to predict who will have normal cognition later in life. Individuals may have higher
baseline functioning (cognitive reserve) and others may maintain or even improve with
age (cognitive resilience). Understanding the mechanisms underlying cognitive reserve
and resilience may hold the key to new therapeutic strategies for maintaining cognitive
health. However, reserve and resilience have been inconsistently defined in human
studies. Additionally, our understanding of the molecular and cellular bases of these
phenomena is poor, compounded by a lack of longitudinal molecular and cognitive data
that fully capture the dynamic trajectories of cognitive aging. Here, we used a genetically
diverse mouse population (B6-BXDs) to characterize individual differences in cognitive
abilities in adulthood and investigate evidence of cognitive reserve and/or resilience in
middle-aged mice. We tested cognitive function at two ages (6 months and 14 months)
using y-maze and contextual fear conditioning. We observed heritable variation in
performance on these traits (h2 RIx = 0.51–0.74), suggesting moderate to strong genetic
control depending on the cognitive domain. Due to the polygenetic nature of cognitive
function, we did not find QTLs significantly associated with y-maze, contextual fear
acquisition (CFA) or memory, or decline in cognitive function at the genome-wide level.
To more precisely interrogate the molecular regulation of variation in these traits, we
employed RNA-seq and identified gene networks related to transcription/translation,
cellular metabolism, and neuronal function that were associated with working memory,
contextual fear memory, and cognitive decline. Using this method, we nominate the
Trio gene as a modulator of working memory ability. Finally, we propose a conceptual
framework for identifying strains exhibiting cognitive reserve and/or resilience to assess
whether these traits can be observed in middle-aged B6-BXDs. Though we found that
earlier cognitive reserve evident early in life protects against cognitive impairment later
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in life, cognitive performance and age-related decline fell along a continuum, with no
clear genotypes emerging as exemplars of exceptional reserve or resilience – leading to
recommendations for future use of aging mouse populations to understand the nature
of cognitive reserve and resilience.
Keywords: cognitive aging, cognitive reserve, cognitive resilience, Weighted Gene Co-expression Network
Analysis, quantitative trait locus mapping, Y-maze, contextual fear conditioning

component. Perhaps unsurprisingly, molecular pathways that
have been implicated in mediating human cognitive aging and
reserve include synaptic function (Honer et al., 2012; ArenazaUrquijo et al., 2015; Lesuis et al., 2018; Kamboh et al., 2019;
Wingo et al., 2019), mitochondrial function (Wingo et al., 2019),
and inflammation (Stacey et al., 2017).
In order to fully understand molecular contributors to
cognitive aging, it will be necessary to study transcriptomic,
proteomic and epigenetic changes across the lifespan and how
they relate to and predict changes in cognitive function. Human
studies of aging often recruit participants in middle age and
necessarily collect brain tissue postmortem, at which point
molecular signatures of those processes underlying the onset
and progression of cognitive aging may have been ongoing for
decades. Even studies that begin sampling cognitive function
earlier in life are unable to capture molecular changes within
the brain until after death, which precludes the possibility
of understanding early molecular regulators of cognitive
reserve and resilience.
Given the challenges in studying the genetics of cognitive
decline in humans, animal models of aging provide a unique and
critical opportunity to study molecular mechanisms of cognitive
aging, as well as cognitive reserve and resilience, across the
lifespan. In this study, we utilized a novel genetic reference
population, an F1 population of C57BL/6J (B6) mice crossed with
27 strains of the BXD genetic reference panel of mice (B6-BXD),
to interrogate molecular mediators of baseline cognitive function
and age-related cognitive decline. The advantage of working with
this population of mice is: (1) a well characterized, diverse and
replicable genome, (2) the ability to sample a range of cognitive
domains in both longitudinal and cross-sectional manners, (3)
the availability of postmortem brain tissue at multiple ages for
assessing gene and protein expression, and (4) the enhanced
ability to identify genetic factors in the B6 genome that may
confer protection against age-related decline. With this panel,
we are able to take advantage of testing reproducible genotypes
in controlled environments to study how age interacts with
genetic background to influence cognitive decline. As in humans,
we found that individual differences in cognitive function and
changes across the lifespan are highly heritable and polygenetic
in nature. To reveal the underlying molecular mechanisms, we
performed RNA sequencing and identified gene co-expression
networks involving intracellular, organelle and neuronal function
whose expression profiles were strongly associated with cognitive
function and cognitive aging. Finally, we evaluated operational
definitions for cognitive reserve, resilience and reserve/resilience
that we pre-registered to assess whether any B6-BXD strains
exemplify cognitive reserve and resilience. From this work, we

INTRODUCTION
Cognitive decline with age, even in the absence of overt dementia,
is common and highly heritable (Dutta et al., 2014; Reynolds
and Finkel, 2015). Cognitive function in old age is an important
predictor of quality of life (Pan et al., 2011, 2015), and developing
strategies to improve cognitive longevity (i.e., ability to maintain
high level of cognitive function into old age) will be critical as
life expectancy continues to increase through modern medicine.
To understand cognitive stability in aging, it is important
to first consider baseline cognitive function: namely, knowing
individuals’ baseline function in early adulthood is necessary
to fully capture cognitive aging trajectories, and understanding
how baseline cognitive function is regulated may help to inform
strategies to maintain those cognitive abilities in aging. Recent
studies have identified over 300 loci associated with general
cognitive function and related traits in adulthood (Davies et al.,
2011, 2015, 2018; Hill et al., 2014; Hibar et al., 2015, 2017;
Trampush et al., 2015; Clarke et al., 2016; Krapohl and Plomin,
2016; Okbay et al., 2016; Sniekers et al., 2017; Savage et al.,
2018; Zabaneh et al., 2018). Given the lack of longitudinal
molecular data, and to a lesser extent, longitudinal cognitive data
from human populations, it remains unclear if the mechanisms
underlying baseline cognitive function also mediate normal
cognitive aging. These factors are highly complex and poorly
understood, despite extensive study (Harris and Deary, 2011; Bis
et al., 2012; De Jager et al., 2012; Davies et al., 2014; Mukherjee
et al., 2014; Zhang and Pierce, 2014; Debette et al., 2015; Lu
et al., 2017; Raj et al., 2017; Tasaki et al., 2018; Yen et al., 2018;
Kamboh et al., 2019; Wingo et al., 2019). Discovering highimpact targets for bolstering baseline cognitive function and
enhancing cognitive longevity will facilitate the development of
pharmacotherapeutics to enhance cognitive health in middleage and beyond.
Identifying molecular networks that promote the maintenance
of cognitive function in aging requires understanding of cognitive
reserve and resilience. Cognitive reserve is often defined as
higher baseline function (Montine et al., 2019), whereas cognitive
resilience is characterized by slower cognitive decline. Reserve
and resilience have often been attributed to environmental
factors; for example, socioeconomic status, education level,
and physical activity are all associated with greater cognitive
reserve and better cognitive status in late adulthood (ArenazaUrquijo et al., 2015; Walhovd et al., 2019; Zahodne et al.,
2019). However, given the heritability of cognitive decline
[∼30–60% genetic control based on twin and community
studies (Swan et al., 1990; McGue and Christensen, 2001;
Harris and Deary, 2011)], there is also a significant genetic
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provide recommendations for incorporating genetically diverse,
recombinant inbred mouse populations for aging studies and
developing definitions of reserve and resilience for animal
studies, as these are needed to advance our understanding of the
mechanisms of reserve and resilience.

alternations were tracked by Any-Maze software. Spontaneous
alternations were defined as successive entries into each arm
before re-entering any arm. Chance performance was defined as
less than 50% correct spontaneous alternations. Animal order
was randomized, and experimenters were blind to mouse strain,
age, and genotype.

MATERIALS AND METHODS

Contextual Fear Conditioning

Animals were kept on a 12 h light/dark cycle and provided
food and water ad libitum. Mice were group-housed (2–5 per
cage). All routine procedures were approved by the Institutional
Animal Care and Use Committee (IACUC) at The University
of Tennessee Health Science Center, and in accordance with
the standards of the Association for the Assessment and
Accreditation of Laboratory Animal Care (AAALAC) and the
National Institutes of Health Guide of the Care and Use of
Laboratory Animals.

To assess contextual fear acquisition (CFA) and long-term
contextual memory (CFM), animals underwent a standard
contextual fear conditioning paradigm (Neuner et al., 2015).
Training consisted of a 150 s baseline period followed by four
footshocks (1 s, 0.9 mA) separated by 140 ± 5 s. A 40 s period
following each shock was considered the postshock (PS) interval.
Total freezing during the fourth PS interval (PS4) was defined
as CFA. To measure CFM, animals were placed in the same
chamber 24 h later for 10 min with no footshocks. Percent time
spent freezing during training and testing was determined using
FreezeFrame software.

Generation of Ntg B6-BXD F1 Panel

Decline Scores

Non-transgenic littermates of the AD-BXD panel were generated
as described in Neuner et al. (2019). Briefly, hemizygous 5XFAD
female mice on a congenic C57BL/6J background were crossed
to male BXD mice (27 BXD strains). One-half of the resultant F1
offspring harbored the 5XFAD transgene to represent a familial
Alzheimer’s disease population (AD-BXDs). The remaining half
of the resultant F1 offspring did not inherit the 5XFAD transgene
and were thus “normal aging” controls. Data collected from
non-transgenic F1 population (B6-BXD) were comprehensively
analyzed and interpreted here, though some behavioral and
molecular data from these non-transgenic littermates was made
available to the research community as controls for the ADBXD panel first reported in Neuner et al., 2019. Because we
had more thorough representation of female animals, we focused
our behavioral and transcriptomic analyses on females only for
this manuscript.

Age-related decline on memory function was determined by
subtracting performance at 6 months from performance at
14 months to achieve a strain average “decline score” in
each memory assay.

Animals

Heritability Calculations
Heritability of behavioral phenotypes was calculated as a ratio
of genetic variance to total variance (genetic + environmental
variance), normalized to the number of biological replicates per
strain (i.e., h2 RI x ; Figure 1A). Heritability scores can range from
0 to 1.0, with an h2 RI x = 1.0 indicating that 100% of the variance
in that trait is controlled by genetics (Belknap, 1998).

Trait and Module QTL Mapping
Genotypes for BXD strains were obtained from
GeneNetwork.org. Quantitative trait locus (QTL) mapping
was performed using the R package qtl2 (Broman et al., 2019)
using the LOCO method for kinship correction (Figure 1A).
Permutation tests (1,000) were used to determine statistical
significance. Power calculations and percent variance explained
were calculated using the R package qtlDesign and reported
in Table 1.

Behavioral Analysis, Phenotype
Derivation
Behavioral tasks (Figure 1A) were described in Neuner et al.,
2019; a subset of these animals (i.e., all female non-transgenic
animals) are described here. A total of 192 animals were included
in the present analyses, and these animals numbers per strain, age,
and assay may be found in Supplementary Table S1. Y-maze was
conducted at both 6 months (n = 171) and 14 months (n = 100),
with animals in the 14 months cohort having been previously
tested at 6 months. The same cohort underwent contextual fear
conditioning as a terminal assay at either 6 months (n = 83) or
14 months (n = 106). Brief descriptions of each phenotyping task
are described below.

RNA Sequencing
RNA sequencing data from the present cohort has been
previously reported in part in Neuner et al. (2019). The previous
publication focused primarily on RNA expression in the 5XFADpositive transgenic littermates (AD-BXDs) of the non-transgenic
mice included herein, with expression data presented for certain
genes of interest in transgenic mice in relation to non-transgenic
mice. Here, we focus on the female non-transgenic B6-BXD
mice only and the gene networks relevant to normal cognition
and cognitive aging (Figure 1B). Sequencing methods were also
described in Neuner et al. (2019). Briefly, hippocampi were snapfrozen at 6 m and 14 m (n = 39 for 6 months, n = 45 for
14 months) immediately following contextual fear conditioning,

Y-Maze
To assess working memory function, mice were placed in a
clear acrylic Y-maze for 8 min. External visual spatial cues
were placed approximately one foot outside of the maze. Mouse
movement was recorded with a video camera and spontaneous
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FIGURE 1 | Schematic of our pipeline to identify mechanisms underlying cognitive function and aging. (A) We cognitively tested a large cohort of B6-BXD mice using
y-maze (working memory) and contextual fear conditioning (short- and long-term memory). We performed quantitative trait locus (QTL) mapping on all traits. (B) We
also performed bulk RNA sequencing of the hippocampus to identify molecular candidates mediating age-related cognitive decline. We analyzed transcriptomic data
on a network level to identify gene networks underlying cognitive traits and age-related decline, as well as gene ontology (GO) terms summarizing the function of
those networks. We also performed individual gene analysis, including identifying network hub genes and genes with high-impact sequence variants to prioritize
genes within networks that underlying variation in cognitive decline.

and RNA was isolated using a Qiacube and RNeasy Mini kit
(Qiagen). Libraries were prepared using Truseq Stranded mRNA
Sample Preparation Kit and sequenced by 75 bp paired-end
sequencing on an Illumina HiSeq2500. We aligned reads from the
non-transgenic female cohort to a diploid B6/D2 transcriptome
using the EMASE pipeline (Raghupathy et al., 2018). Genes were
filtered to require an average of at least 1 transcript per million
in 50% of the samples and averaged across age and strain for
downstream analyses. 15,327 genes survived this filter and were
included in our final analyses.

Hub Gene Analysis
Module hub genes were defined as the gene with the highest
connectivity in each module and identified using the function
“chooseTopHubInEachModule” in the WGCNA R package.

Trait-Expression Correlations (Figure 1B)
To identify modules that were significantly associated with each
given trait, we calculated the Pearson’s correlation coefficient of
the module eigengene with each cognitive trait. Co-expression
modules were identified as showing significant associations with
a trait with an FDR < 0.05.

Gene Co-expression Network Analysis

Co-expression Module Characterization (Figure 1B)

Co-expressed gene modules were generated from 6-months,
14 months, and population-wide female non-transgenic
B6-BXD RNA-seq data by Weighted Gene Co-expression
Network Analysis (WGCNA) (Langfelder and Horvath, 2008).
A minimum module size of 30 was implemented, and the
modules were assembled by block-wise network construction. In
this study, the power β with scale-free R2 > 0.80 was adopted as
a soft-thresholding index to construct a scale-free co-expression
network. Module eigengene expression values from each module
were used for downstream analyses.

To characterize genes within our WGCNA modules, we
performed functional enrichment analysis using the R package
anRichment. Results were filtered to include only “Biological
process” and “Molecular function” GO terms. FDR < 0.05 was
used as the threshold to identify GO terms/pathways significantly
enriched within each of the modules.

Identification of Sequence Variants
For genes of interest, we used the Sanger Mouse Genomes
Project SNP Query tool1 to identify sequence variants (SNPs,
Indels, and structural variants) between the C56BL/6J and
DBA/2J mouse strains, the parental strains of the BXD panel.
Variant consequences are predicted using the Ensembl Variant
Effect Predictor.

TABLE 1 | Heritability and QTL power calculation results for each cognitive trait.
Trait

h2 RI x

Peak marker
SNP

Power

Minimum percent
variance explained
by peak marker

Y-maze (6 months)

0.51

rs29776171

0.82

44.2%

Y-maze (14 months)

0.62

rs29525970

0.84

47.1%

CFA (6 months)

0.69

rs31878001

0.007

6.3%

CFA (14 months)

0.68

rs215717346

0.95

56.4%

CFM (6 months)

0.64

Affy_PC2_15

0.94

53.9%

CFM (14 months)

0.74

Affy_17539964

0.87

51.4%
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Statistics
Statistics were completed in R and figures were generated using
the R packages ggplot2 (cognitive performance, reserve/resilience
plots), corrplot (correlation matrices), and qtl2 (QTL plots),
or Microsoft Excel (module enrichment plots). Significance
1

4

https://www.sanger.ac.uk/sanger/Mouse_SnpViewer/rel-1505
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positively associated with strain differences in working memory
performance at 6 months (Figure 2D). These modules were
associated with functions encompassing cellular metabolism
(lightyellow; R = 0.62, nominal p-value = 0.004; 23 significant
GO terms by FDR < 0.05), RNA and protein localization
(saddlebrown; R = 0.56, p-value = 0.02; 9 significant GO terms
by FDR < 0.05), DNA stability (darkred; R = 0.47, p = 0.049;
36 significant GO terms by FDR < 0.05), and receptor recycling
(darkolivegreen, p-value = 0.02; 9 significant GO terms by
FDR < 0.05) (see Table 2 for hub genes and top GO significant
terms by enrichment ratio for these modules). The most strongly
correlated module, lightyellow, was regulated by its hub gene,
Trio, a guanine nucleotide exchange factor. Trio is important
in neuronal development and synapse function and has been
previously associated with cognitive ability: mutations in TRIO
lead to intellectual disability in humans (Ba et al., 2016; Pengelly
et al., 2016), and hippocampal and cortical knockout of Trio leads
to impaired learning in memory in mice (Zong et al., 2015). There
is one missense variant in Trio in the DBA/2J genome compared
to the C57BL/6J genome. This variant (Chr 15:27752684, a/c) is
within the coding region of Trio and results in a change from
a valine to glycine and has a SIFT (Sorting Intolerant From
Tolerant) score of 0, indicating a deleterious effect on protein
expression. This indicates that there is likely differential function
of Trio across our B6-BXD cohort that may disrupt the larger
lightyellow network, associated cellular metabolism pathways,
and ultimately working memory ability (Figure 2E).
At 14 months, working memory was correlated with the
two modules, only one of which (greenyellow) was significantly
enriched for GO terms (R = −0.48, p-value = 0.008; 31 significant
GO terms by FDR < 0.05; Figure 2F and Table 3). This
module was enriched for genes associated with DNA binding and
metabolism pathways, and is regulated by its hub gene, Ptpn6–
a protein tyrosine phosphatase. Ptpn6 has not previously been
associated with learning and memory, though protein stability
and specifically protein phosphatases are important for learning,
memory, and synaptic functions (Graff et al., 2010). These data
suggest that disrupted nucleic acid metabolism may be associated
with poorer cognitive function in aging.

thresholds were set to alpha = 0.05 and adjusted for multiple
corrections as specified.

RESULTS
Working Memory Is Heritable,
Polygenetic, and Regulated by Cellular
Metabolism Transcriptomic Pathways
We assessed hippocampus-dependent working memory by
measuring spontaneous alternations in y-maze at both 6 months
and 14 months of age (Figure 2A). A majority of strains
had a mean performance above chance (i.e., 50% spontaneous
alternations) at 6 months, demonstrating that these mice were
generally able to perform this task at baseline. We also performed
one-sample t-tests within each strain (with n > 2) to identify
which strains performed statistically significantly above chance.
Several strains did not perform significantly above chance levels
(CI = 99%; see Supplementary Table S2 for a summary of
these one-sample t-tests), though this is likely due to reduced
power given the relatively low number of biological replicates
per strain required for such a study using a genetic reference
panel. By 14 months, two of the 25 strains tested (B6-BXD62
and B6-BXD14) had a mean (±standard error) performance
below chance, indicating vulnerability to cognitive impairment
by middle age, and all but three strains (B6-BXD56, B6-BXD77,
B6-BXD81; see Supplementary Table S3 for a summary of
these t-tests) were performing statistically equal to chance by
one-sample t-tests. We then calculated heritability, h2 RI x , to
determine the proportion of trait variation that is genetically
controlled. Heritability of working memory improved with age
(h2 RI x = 0.51 at 6 months vs. 0.62 at 14 months – or 51% and
62% of the variance at 6 and 14 months, respectively, may be
attributed to genetic factors) (Figure 2B and Table 1). Such
high heritability of working memory implies genetic control; to
identify potential genetic drivers of these traits, we performed
QTL mapping. QTL mapping revealed no single locus controlling
a significant proportion of the variance on performance on
y-maze at either 6 months or 14 months of age (Figure 2C), or
combined with age as a covariate (data not shown). We then
employed RNA sequencing to identify mechanisms underlying
the variation in working memory.
We performed weighted gene co-expression network analysis
(WGCNA) from 6 to 14 months RNA-seq data to identify
clusters of genes (i.e., modules) that have highly correlated
expression across our population. We calculated Pearson’s
correlations for expression of each module (i.e., expression of
the module eigengene) with cognitive function at concurrent
time points (i.e., 6 months RNA expression to 6 months
phenotypes and 14 months RNA expression to 14 months
phenotypes) to determine which modules were most likely
underlying working memory. To characterize each module,
we identified the hub gene most highly connected within the
module, and performed gene ontology (GO) enrichment to
describe biological pathways and molecular functions associated
with each module. Four WGCNA modules were significantly
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Contextual Fear Acquisition and Memory
Are Not Significantly Regulated by
Specific Genomic Loci
To assess hippocampus-dependent acquisition of contextual fear
memory in young adulthood, animals underwent contextual
fear conditioning (Figure 3A). Acquisition of contextual fear
conditioning (CFA) was highly heritable, as measured by
comparing within strain versus across strain variability using
percent freezing during the interval following the fourth shock
(postshock 4 interval; h2 RI x = 0.69 at 6 months) (Figure 3B).
The high degree of heritability indicates strong genetic control,
therefore we performed QTL mapping for CFA (using mean
freezing in the final postshock interval) and did not identify
any locus significantly associated with this trait. Similarly,
although contextual fear memory was also highly heritable
(CFM; h2 RI x = 0.64 at 6 months), we did not identify any loci
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FIGURE 2 | Variation in working memory is heritable in early adulthood (6 months) and middle age (14 months) but is not significantly controlled by a single genetic
locus. (A) We used the y-maze as a test of working memory in B6-BXD mice at both 6 months and 14 months. In this version of the y-maze test, we used visual
cues placed outside of the maze and allowed the mouse to freely explore each arm. Entering each of the three arms in succession was considered a successful
spontaneous alternation (“Spon Alt”). (B) Performance on the y-maze test is heritable (h2 RIx = 0.51 at 6 months and 0.62 at 14 months). (C) Quantitative trait locus
mapping indicated that no single genetic locus contributed significantly to performance on the y-maze at either age, suggesting that working memory is a
polygenetic trait. (D) The relationship between each WGCNA module eigengene expression and cognitive function at 6 months was assessed using Pearson
correlations. Significant correlations are represented by blue (positive correlation) or red (negative correlation) shading, with color intensity corresponding with
correlation strength. Four WGCNA modules were associated with y-maze at 6 months: darkolivegreen, darkred, lightyellow, and saddlebrown. (E) Expression of the
lightyellow module was significantly positively associated with working memory at 6 months (R = 0.57, p = 0.004); however, expression of the hub gene of this
module Trio, was not significantly associated with working memory (R = −0.38, p = 0.07). (F) Two modules at 14 months were significantly correlated to
performance on y-maze at 14 months: greenyellow and darkolivegreen. QTL significance thresholds: red line, alpha = 0.05; black line, alpha = 0.33.
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significantly associated with contextual fear memory, suggesting
polygenetic control of long-term contextual fear memory at
6 months (Figure 3C).

TABLE 3 | Top GO terms and hub genes for 14 months gene modules
significantly associated with 14 months cognitive function.
WGCNA Module Associated Top GO term (top enrichment
phenotype score with p < 0.05)

Contextual Fear Acquisition and Memory
in Young Adulthood (6 Months) Are
Associated With Gene Networks
Involved in Cell Metabolism and Gene
Transcription
Here, we turned to WGCNA to identify gene co-expression
networks underlying performance on CFA and CFM
(Figure 3D). CFA at 6 months was significantly associated
with two WGCNA modules (Figure 3D). The module with
the strongest positive association with CFA, lightgreen
(R = 0.34, p-value = 0.01), was significantly enriched for
39 GO terms encompassing cellular metabolism and gene
transcription (FDR < 0.05). Similarly, the red module was
significantly positively associated with CFM (R = 0.43,
p-value = 0.04) and was also significantly enriched for 50
GO terms encompassing gene transcription and protein
synthesis pathways (FDR < 0.05; See Table 2 for top
GO terms and hub genes for these modules). These
data highlight the requirement of synapse remodeling
and protein expression changes in learning and memory
consolidation in a task such as fear conditioning
(Alberini and Kandel, 2015).

darkolivegreen

Y-maze

None

Usp2

greenyellow

Y-maze

DNA recombination

Ptpn6

plum1

CFA

retrograde vesicle-mediated
transport, Golgi to ER

tan

CFA

regulation of transcription,
DNA-templated

6 months
WGCNA
Module

Nkrf

Associated
phenotype

Top GO term (top enrichment
score with p < 0.05)

Hub gene

blue

14 months
CFA

receptor localization to synapse

Glg1

darkgreen

14 months
CFA

central nervous system myelination

Cnp

darkgray

CFA decline

n/a

darkmagenta

14 months
CFM, CFM
decline

binding

Eda

darkorange

14 months
CFA, CFA
decline

GPI-anchor transamidase activity

Ngb

darkturquoise
greenyellow
orange

We then looked at performance on contextual fear conditioning
in middle age (14 months). Although performance on both
CFA and CFM was highly heritable at 14 months (CFA:
h2 RI x = 0.68 at 14 months; CFM: h2 RI x = 0.74 at 14 months;
Table 3), QTL mapping revealed no genome-wide loci associated
with either CFA or CFM at 14 months (Figure 4A), again
hinting at the highly polygenetic nature of these traits. To

TABLE 2 | Top GO terms and hub genes for 6 months gene modules significantly
associated with 6 months cognitive function.

CFM decline,
CFA decline
14 months
CFA
CFM decline

pink

14 months
CFA

tan

14 months
CFA, CFM
decline, CFA
decline

Klhl23

response to cold

Cnrip1

regulation of transcription involved in
meiotic cell cycle

Kat2b

U1 snRNP binding

Otub2

structural constituent of ribosome

Eml5

cellular localization

Nkrf

turquoise

14 months
CFA, CFA
decline

syntaxin binding

Mdfic

white

CFA decline

protein binding

Gm22291

yellow

14 months
CFA

rRNA processing

Gria1

Hub gene

darkolivegreen

Y-maze

positive regulation of receptor
recycling

darkred

Y-maze

DNA topoisomerase type I activity

lightyellow

Y-maze

heterocyclic compound binding

saddlebrown

Y-maze

establishment of protein localization Smim10l2a
to Golgi

interrogate the molecular underpinnings of phenotypic variation
of contextual fear conditioning in middle age, we again turned
to WGCNA. Here, two modules were significantly positively
correlated with CFA (tan: R = 0.41, p-value = 0.049, 37 significant
GO terms by FDR < 0.05; plum1: R = 0.40, p-value = 0.03, 1
significant GO term by FDR < 0.05), and no modules correlated
with CFM in middle age (Figure 4B). Similar to modules
underlying CFA and CFM at 6 months, networks important in
gene transcription and biosynthesis (tan module), and protein
transport (plum1 module) were important in regulating CFA
at 14 months (see Table 4 for top GO terms and hub genes
for these modules).

Krt2
Cfap20
Trio

black

CFA

regulation of cell differentiation

lightgreen

CFA

positive regulation of protein
targeting to mitochondrion

Mccc1

paleturquoise

CFM

ubiquitin-ubiquitin ligase activity

Herc3

red

CFM

cellular response to stress
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TABLE 4 | Top GO terms and hub genes for 6 months gene modules significantly
associated with later (14 months) cognitive function and/or decline.

Wide Variation in Cognitive Performance
of 14 Months (Middle-Aged) Mice Is
Regulated by Networks Involved in Gene
Transcription

WGCNA Module Associated Top GO term (top enrichment
phenotype score with FDR < 0.05)

Hub gene

Qars

Szt2
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FIGURE 3 | Variation in short- and long-term memory is heritable and not controlled by a single genetic mechanism at 6 months of age. (A) B6-BXD mice underwent
contextual fear conditioning to assess short- and long-term memory. Mice received four mild footshocks and were tested for contextual memory by measuring
freezing 24 h later. (B) Contextual fear acquisition, or freezing during the postshock 4 (PS4) interval, was heritable (h2 RIx = 0.69) at 6 months. QTL mapping revealed
that no locus was significantly associated with performance on contextual fear acquisition. (C) Contextual fear memory performance is also highly heritable
(h2 RIx = 0.64); however, QTL mapping failed to identify significant loci controlling contextual fear memory. (D) Four WGCNA modules were associated with contextual
fear conditioning traits at 6 months: CFA was significantly associated with the lightgreen and black modules’ expression. CFM was significantly associated with the
paleturquoise and red modules’ expression. QTL significance thresholds: red line, alpha = 0.05; black line, alpha = 0.33.

cognitive performance declined with age. We found a significant
main effect of age on y-maze by ANOVA (F = 18.54, p < 0.001),
though there was no significant effect of age by ANOVA at
the population level on contextual fear memory traits (CFA:
F = 0.422, p = 0.52; CFM: F = 2.48, p = 0.11). We then calculated
a “decline score” for each strain on each trait: this was done by
subtracting strain average performance at baseline (6 months,
adult) from performance at 14 months (middle-aged).

Age-Related Cognitive Decline Is
Polygenetic and Predicted by 6 Months
Neuronal Gene Networks
One strength of our B6-BXD model of cognitive aging is that
each strain has a stable, reproducible genome and as such
may be resampled to assess individual strain differences agerelated cognitive decline. In general, in our B6-BXD population,
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FIGURE 4 | Contextual fear conditioning performance in middle age is also highly heritable and polygenetic, and is associated with neuronal function. (A) Contextual
fear acquisition and contextual fear memory were both highly heritable at 14 months (CFA: h2 RIx = 0.68, CFM: h2 RIx = 0.74), though we did not identify any
significant locus associated with CFA or CFM in middle age. (B) We identified two WGCNA modules that were associated with CFA, but not CFM, at 14 months.

decline. We observed several strong associations between
gene expression in earlier adulthood (6 months) and later
performance and decline on contextual fear conditioning
(14 months), with 13 modules’ expression at 6 months
significantly correlated with performance and/or decline on
one or more of the measured cognitive domains (Figure 5D).
These modules were enriched largely for neuronal pathways
and gene transcription. In particular, myelination and synaptic
function at 6 months were strongly associated with later
cognitive function and decline (see Table 4 for top GO
terms and hub genes for each module). This suggests that
maintenance of cognitive function through middle age may
be particularly regulated by both neuronal function and
gene transcription/protein stability. More broadly, the strong
relationships between hippocampal gene expression in earlier
adulthood and mid-life cognitive performance suggests that
age-related cognitive decline is sensitive to early life molecular
processes, and that interventions to prevent age-related
cognitive decline should target these early perturbations in
relevant gene networks.

The majority of strains (17/24) showed poorer working
memory at 14 months compared to 6 months (Figure 5A).
However, only about half of the strains exhibited declined on
CFA and memory, 12/22 and 14/22, respectively with age, and
some performed better at mid-life (Figures 5B,C). These data
indicate strong individual differences in cognitive decline that
may be genetically controlled and resolved through genetic
mapping. We thus performed QTL mapping on cognitive
decline scores generated for working memory, CFA and CFM,
and did not identify any loci significantly associated with
cognitive decline on any of the traits measured. These data
suggest that, like in the human population, complex polygenetic
interactions determine the rate of cognitive decline in our
mice, where no single locus had a sufficiently large effect size
for us to detect given our sample size (Figures 5A–C). This
finding is another indication of the translational relevance
of our model; an additional advantage this model has over
human populations is that we were then able to turn to
longitudinal hippocampal brain transcriptomic co-expression
networks to interrogate the molecular networks underlying
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FIGURE 5 | Cognitive decline is polygenetic and may be predicted by early life gene co-expression networks. (A) B6-BXD strains generally declined on working
memory between 6 and 14 months of age, though there was wide variation in degree of change. QTL mapping revealed no significant locus regulating this decline.
(B,C) B6-BXD strains showed a wide range in change in performance on contextual fear conditioning between 6 and 14 months. Again, no single locus was
associated with decline on either contextual fear acquisition or memory. (D) We identified several WGCNA modules whose expression at 6 months were significantly
associated with later performance and/or decline on contextual fear acquisition and memory.

(6 months) performance and calculated the Pearson’s R to assess
whether there was a correlation between early life and midlife
cognitive function. We saw no association between early y-maze
performance and later y-maze performance (Figure 6A; R = 0.11,
p = 0.61), suggesting that better performance at young ages on
this task does not confer protection against decline in working
memory. However, better performance on contextual fear CFA
and CFM in adulthood predicted superior memory performance
on CFM in middle-aged mice (Figures 6B,C; CFA: R = 0.46,

Characterization of Cognitive Reserve
and Resilience in the B6-BXDs
To assess whether higher baseline cognitive function results in
better cognitive function in aging (i.e., early cognitive reserve
conferring protection against later decline) (Cook and Fletcher,
2015; Lesuis et al., 2018; Bettcher et al., 2019; Walhovd et al., 2019;
Zahodne et al., 2019), we compared baseline cognitive function at
6 months to later cognitive performance at 14 months. To do this,
we plotted later (14 months) performance as a function of earlier
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FIGURE 6 | Early performance on contextual fear memory, but not y-maze, predicts later performance. (A) Pearson’s correlation indicates no significant relationship
between early (6 months) and later (14 months) performance on the y-maze test (R = 0.11, p = 0.61). Gray dashed lines in the y-maze plot indicate 50%
spontaneous alternations, or chance performance. Performance below 50% indicates cognitive impairment on this test. Error bars represent standard error. (B,C)
Pearson’s correlation indicates that early (6 months) performance on contextual fear conditioning predicts later (14 months) performance by both CFA and CFM.
Better performance at 6 months predicts better relative performance at 14 months (R = 0.46, p = 0.03 for CFA; R = 0.43, p = 0.04 for CFM). (D–F) Pearson’s
correlations indicate that higher performance in early adulthood (6 months) is associated with greater decline by midlife (14 months), particularly in short- and
long-term memory (R = −0.37, p = 0.06 for y-maze; R = −0.58, p = 0.004 for CFA; R = −0.46, p = 0.03 for CFM). ∗ p < 0.05; ∗∗ p < 0.01.

p = 0.03; CFM: R = 0.43, p = 0.04). These data suggest short-term
and long-term memory performance later in life is protected to
some degree by either having greater cognitive reserve evident in
early adulthood or cognitive resilience protecting against decline
in midlife. To further clarify this, we next asked whether higher
baseline (6 months) function protected against cognitive decline.
In fact, higher performance at 6 months generally resulted in
greater decline by 14 months (Figures 6D–F), which may simply
reflect the mathematically greater potential for decline in baseline
high-performers, or it may reflect the ability of greater cognitive
reserve to protect against cognitive impairment even when an
individual experiences cognitive decline from their own baseline.

resilience. We expected that a small number of B6-BXD strains
might exemplify either cognitive reserve or resilience by middleage given the variation in cognitive decline we observed, so we
first objectively defined reserve and resilience, preregistered these
definitions, and then tested whether any strains in our population
met these criteria. This definition and identification of potential
“strains of interest” will be particularly useful for future studies –
both using the BXD panel to more deeply characterize resilience
and reserve within these strains, and also to inform human
studies toward a more mechanistic definition of “reserve” and
“resilience” based in the biological processes underlying these
characteristics.
Cognitive reserve is commonly defined as higher cognitive
function at baseline (Montine et al., 2019; Figure 7A, pink
and green lines), which allows for more cognitive flexibility
and buffering against cognitive decline. For our definition, we
considered strains in the top quartile to display cognitive reserve.
Higher cognitive function at baseline allows for “reserve capacity”
to buffer against any cognitive decline, but does not necessarily
stem cognitive decline. However, because cognitive reserve
necessarily should protect against later cognitive impairment
(regardless of decline from baseline), and because our terminal
time point (14 months) is in middle age for mice, we also
required strains with cognitive reserve to still function above the
median population performance at 14 months. Ideally, cognitive

Working Definition of Cognitive Reserve and
Resilience
Because our population-level data hinted at a role for cognitive
reserve or resilience protecting against midlife cognitive decline,
we sought to objectively operationally define cognitive reserve
and resilience using our B6-BXD population and identify
individual strains which may represent these cognitive aging
strategies. In Figure 7A, we demonstrate hypothetical cognitive
trajectories for normal aging (black line), dementia (red), and
cognitive aging in populations with cognitive reserve (pink)
and/or resilience (blue, green). In these latter cases, cognitive
decline is buffered by cognitive reserve and slowed by cognitive
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FIGURE 7 | Complex cognitive trajectories in aging may be modeled in the B6-BXD mice. (A) Visualization of idealized data exemplifying cognitive functional decline
in normal aging (gradual decline after midlife; black line), dementia (rapid decline to impairment in midlife; red line), cognitive reserve (higher baseline; pink line),
cognitive resilience (slower decline; blue line), or both cognitive reserve and resilience (green line). Individuals with intellectual disability or impaired performance at
baseline (orange line) are typically excluded from human studies in cognitive aging. (B,C) We identified strains displaying suggestive reserve and/or resilience on
individual cognitive measures; these strains remain only suggestively in their categories because, though strain averages fall within the limits of our definitions,
within-strain variability exceeded our margins of error in every case. For individual traits, B6-BXD100 and B6-BXD56 were suggestive resilient strains, and B6-BXD69
(Continued)
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FIGURE 7 | Continued
and B6-BXD61 were suggestive reserve + resilient strains in y-maze. B6-BXD68 was a suggestive resilient strain, and B6-BXD51 and B6 homozygotes were
suggestive reserve + resilient strains in CFM. Right panels: We also calculated a composite score for cognitive performance across three traits (y-maze, CFA, and
CFM) by summing the z-score for each trait within each strain. B6-BXD68 was a suggestive resilient strain, and B6-BXD51 and B6-BXD56 were suggestive reserve
strains. (D) Strains that had baseline (6 months) performance below the 3rd Quartile (i.e., no cognitive reserve), midlife (14 months) performance below the median
(i.e., insufficient cognitive reserve), or a greater than average rate of decline (i.e., no cognitive resilience) were considered “normal agers”. For (B–E), color scheme is
as in (A). Black dashed line is median, gray dashed lines are 1st and 3rd quartile. For ease of visualization, each category of aging trajectory was visualized
separately. Strains with n < 2 at either time point were excluded from categorization and visualization. (E) Strains with baseline performance below the 1st quartile
were considered impaired.

contextual fear memory (Figure 7C, green lines). Most strains
fell within “normal aging” parameters (that is, starting within
the middle quartile ranges at baseline and/or not meeting our
reserve/resilience criteria). In Figure 7E, we identified several
strains (orange lines) whose baseline performance fell below
the first quartile (lower gray dashed lines in Figures 7B–E),
suggesting baseline impairment.
Further characterization of these strains to specifically test for
and more deeply characterize cognitive reserve and resilience
will be necessary, including aging mice much longer (e.g., to
22 months or older), though we demonstrate here that the B6BXD population is a powerful tool to begin understanding the
nature of reserve and resilience and to identify the molecular
networks underlying these traits.

reserve and resilience would manifest globally, or protect against
impairment across cognitive domains (i.e., working, short-term,
and long-term memory in our dataset), so in addition to
individual cognitive traits, we also calculated a composite score
for cognitive function by calculating z-scores for each strain for
each cognitive trait and timepoint, and summing these scores to
achieve a composite score.
Resiliency to cognitive decline is commonly defined as a
relatively slow rate of decline over time (e.g., the annual rate of
change in humans; Figure 7A green and blue lines) (Montine
et al., 2019). Though performance across the spectrum (from
“good” performers to “poor” performers at baseline) may be
stable across time and thus display a type of resilience to decline,
we required that strains that displayed “true” resilience to be
relatively good performers at baseline (i.e., performing above the
median as indicated by the black dashed line in Figures 7B–E)
and to decline more slowly than average. Initially, we defined
slow decline as “no significant difference from 6 to 14 months
performance.” However, this criterion proved too permissive, as
few individual strains exhibited significant decline after adjusting
for multiple comparisons (see previous sections). Our final
definition of cognitive resilience required strains start above
median population performance (indicated in Figures 7B–E as
the middle black dashed lines) and have an “annual rate of
decline” (or decline slope) slower than average.
Finally, in identifying strains that met these definitions,
we required that strain average ± strain standard error fit
within these criteria. Ultimately, these strains fell along a
continuum of cognitive performance and decline, and due to
the within-strain variance, no single strain exemplified true
reserve or resilience based on our working definition. We
identified strains that may potentially fit these definitions given
more thorough characterization and a higher sample size; these
“suggestive” strains may be promising strains to investigate
with a higher sample size to identify molecular signatures of
reserve and/or resilience and are delineated in Figures 7B–E.
For ease of visualization, we have plotted resilience, reserve and
reserve/resilience, normal aging, and impaired strains in separate
plots. Strains with an n < 2 at any given timepoint were excluded
from these visualizations, as we were unable to assess withinstrain variance. Strains meeting suggestive criteria for reserve and
resilience included: for resilience, B6-BXD100 and B6-BXD56
for working memory and B6-BXD68 for long-term memory
and in our composite cognitive score (Figure 7B, blue lines);
for reserve, B6-BXD51 and B6-BXD56 with composite cognitive
score (Figure 7C, pink lines); for reserve + resilience, B6-BXD61
and B6-BXD69 for working memory, and B6 and B6-BXD51 in
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DISCUSSION
Genetics of cognition, cognitive decline, and cognitive reserve are
highly complex and difficult to study in humans. However, as we
make strides in improving lifespan, increasing cognitive longevity
should become a priority in order to maximize quality of life
in old age. Understanding the molecular mediators of baseline
cognitive function, cognitive reserve, resiliency and susceptibility
with regards to age-related cognitive decline and identification
of novel pharmacological targets/pathways regulating cognitive
health may allow cognitive health span to catch up to lifespan
improvements afforded by modern medicine. To achieve these
goals, we first need to identify models that can best address
these questions. Here, we have utilized a novel model of agerelated cognitive decline to extract genetic mediators of normal
cognitive function and age-related decline. Because our B6BXD population is a recombinant inbred backcross rather than
a homozygous BXD population, the result is enrichment for
identifying B6 effects on phenotypes by genetic mapping, and a
loss of detecting recessive D2 effects. However, given the great
interest in identifying genetic factors harbored by the B6 strain
that confer documented resilience against cognitive impairment
compared to D2 (Neuner et al., 2019), we hypothesized we would
identify genetic resilience mechanisms within our population.

We Observed Heritable Variation in
Cognitive Tasks and Age-Related
Cognitive Decline
The heritability estimates (h2 RI x ) of working, short- and longterm memory ranged from 0.51 to 0.74, indicating that these
traits are strongly genetically controlled. However, QTL mapping
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AD-BXD and B6-BXD populations did have pathways enriched
in neuronal function in common. These findings suggest
that an individual’s risk for disease-related cognitive decline
versus “normal” aging mechanisms may have some common
elements (e.g., neuronal function); though we also observe
an interesting divergence in pathways, where disease may be
regulated by neuroinflammatory processes, and normal aging
may be regulated by cell metabolism and maintenance of proper
gene expression and nucleic acid stability.
Intriguingly, we identified the strongest and most numerous
gene co-expression network-trait associations between 6 months
gene expression and later cognitive function and decline. This
indicates that variation in gene expression in early adulthood
may likely determine cognitive decline, rather than later gene
expression perturbations being most significant to underlying in
cognitive decline. In addition to implying that interventions must
happen early in order to curb age-related cognitive decline, this
also highlights the value in collecting behavioral data and brain
molecular information at early time points, a process which is
impossible in human studies. Thus, to understand the molecular
mechanisms of cognitive aging, we need to focus on animal
models such as our B6-BXD population where we are able to
sample timepoints across the lifespan.

identified no single significant peak associated with any trait,
meaning that no individual genetic locus accounted for a
substantial proportion of the variance on these traits as could
be detected by our sample size. These data indicate that
cognitive function is polygenetic and controlled by many variants
with small effect sizes, as we did not identify additional loci
associated with later cognitive function or cognitive decline.
This is not surprising, given recent GWAS in humans have
found hundreds of SNPs associated with cognitive function
and other highly complex traits (Davies et al., 2018). Given
the importance of understanding the molecular contributors to
cognitive function and reserve against decline with age, though,
we sought to develop alternative approaches to identifying genes
and pathways that mediate cognitive function and promoting
cognitive reserve and resilience.

Prioritization of Molecular/Genetic
Candidates of Cognitive Function and
Decline in Adulthood
To complement our QTL mapping and to identify gene
networks underlying complex cognitive traits, we conducted
molecular experiments to identify target genes associated with
cognition. We performed RNA sequencing followed by weighted
gene co-expression analysis (WGCNA), and measured the
association of WGCNA modules and individual genes with
level of cognitive performance and decline. We identified
pathways and highly interconnected “hub” genes from our
WGCNA modules, which are functionally important within gene
networks and may represent candidate genes and mechanisms
underlying “normal” cognitive aging. Given that cognitive
function and decline are incredibly complex and are affected
by a wide range of factors, we hypothesized that associated
gene networks would be more biologically relevant than
single candidate genes, and provide more insight to the
mechanisms underlying cognitive function and decline. These
gene networks, in turn, may be manipulated therapeutically
by targeting their hub genes with the goal of enhancing
cognitive function in aging. Perhaps unsurprisingly, the modules
that were most significantly associated with cognitive function
in adulthood were enriched for GO terms associated with
cellular metabolism and transcription/translation, highlighting
the importance of physical remodeling of synapses in learning
and memory through regulation of gene transcription and
protein expression/localization (Alberini and Kandel, 2015).
Notably, evidence from postmortem human brain studies suggest
that synapse or dendritic spine remodeling is a primary
neurobiological mechanism of cognitive resilience to aging and
Alzheimer’s disease pathology (Boros et al., 2017, 2019).
As with baseline cognitive function, we also identified
gene
networks
that
primarily
included
neuronal,
transcription/translation, and cellular metabolism functions
as underlying cognitive decline. This was in contrast to our
previous analyses of our genetically diverse population of mice
with familial Alzheimer’s disease mutations (AD-BXDs; Neuner
et al., 2019), where we observed largely neuroinflammatory
pathways as underlying AD-related cognitive decline. Our
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Identifying Strains Characterized by
Cognitive Reserve and Resilience in the
B6-BXD Population
Finally, we assessed whether we observe cognitive reserve and
resilience in our population of mice. In human literature,
cognitive reserve and resilience are inconsistently defined, which
has contributed to a general lack of focus in understanding
of the mechanisms underlying these processes. For example,
many studies use “years of education”–or related measures
such as being multilingual or having a cognitively engaging
occupation–as a proxy for cognitive reserve. Defining cognitive
reserve in this way is problematic for multiple reasons: namely,
though the two are often correlated, we do not believe that
socioeconomic opportunity is intrinsically required for cognitive
reserve. Additionally, to study cognitive reserve in animals–
and the genetic basis thereof–we also cannot rely on external
factors such as education that are inapplicable to animals.
Cognitive reserve is likely plastic and may be enhanced by
environmental enrichment in both humans and animals – an
additional goal of our laboratory will be to evaluate individual
differences in how environmental enrichment may enhance
cognitive reserve.
Cognitive resilience has also been inconsistently defined in the
literature and often implies resilience to disease-related processes,
such as atrophy or neurodegenerative disease pathologies.
We sought to define cognitive resilience behaviorally, and in
the future will extend this definition to identify anatomical,
cellular, molecular signatures of cognitive resilience to maximize
translatability to human studies (Bettcher et al., 2019). Namely,
we required that cognitive resilience was characterized by slow
(or non-existent) cognitive decline over time. Our late-life
timepoint for measuring cognitive function was 14 months,
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candidate molecular mechanisms for successful cognitive aging
that may, in turn, be used to develop therapeutics to prevent
age-related cognitive impairment.

which approximates middle age. Although 14 months is not
considered “aged” for these strains of mice, this does raise
an important point in the context of translatability of these
measures: in human studies, participants are typically enrolled in
mid-life when some degree of cognitive decline may have already
occurred, even if “control” participants are still performing
cognitive tasks well. A strength of our mouse model is the ability
to sample both cognitive and molecular data at early time points
to relate early changes with mid- and late-life cognitive function.
Our observation that gene perturbations in early adulthood (i.e.,
6 months) may be more important in regulating cognitive decline
than later transcriptomic changes indicates that human studies
may be starting too late to fully characterize reserve and resilience
trajectories and mechanisms. On the other hand, our study likely
ended too early (middle age) and thus we were unable to observe
robust effects of cognitive resilience. It is likely that to truly
identify cognitive resilience to age-related decline, we will need
to observe cognitive function through late life, or to at least a
22–24 months timepoint.
Ultimately, we established a stringent set of criteria to
operationally define cognitive reserve and resilience in the B6BXD population that may be extended to other animal models
as well as human studies. First, we required that animals
with cognitive reserve have baseline functioning in the upper
quartile. We expected that cognitive reserve would vary based
on cognitive domain – that is, strains could display cognitive
reserve as measured by one or a subset of tasks. We also expect
that cognitive reserve functions to protect against cognitive
impairment with age, so we also required that strains would still
be performing at or above median performance by 14 months.
We expected the effects of cognitive resilience to be global
and exhibit protection against decline across cognitive domains.
In this case, we required strains with cognitive resilience to
start at or above the median population performance. We also
required that there be no significant decline in cognitive function
between 6 and 14 months. To fit within these criteria, strains
would have to perform on average, ±standard error, within
their category. In our population, we did not observe sufficient
evidence to identify true exemplars of cognitive reserve or
resilience, though we were able to identify multiple strains that
may represent either cognitive reserve, resilience or both. Thus,
with our criteria, we will need additional biological replicates
per strain, and likely additional strains, to fully capture cognitive
reserve and resilience. This highlights the main advantage of
our mouse model of normal aging: because each strain has
a replicable genome, we are able to add biological replicates
to more deeply characterize any strain or trait of interest.
In the future, we will expand our studies to include more
strains, more animals per strain, and extended timepoints in
order to capture the a more precise picture of within-strain
performance and a full range of cognitive performance and
decline. This will allow us to identify molecular signatures of
cognitive reserve and resilience in our B6-BXD population, and –
most importantly – assess the translational potential of these
findings to human studies. By establishing objective definitions
of cognitive reserve and resilience, and by identifying mouse
models of these traits, we will be able to inform human studies of
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CONCLUSION
Harnessing the underlying mechanisms of cognitive reserve
and resilience will be a promising strategy to maintaining
cognitive health until late life. Our understanding of the
molecular underpinnings of reserve and resilience have been
limited, but the development and usage of animal models of
these processes, such as the B6-BXD recombinant inbred lines
described herein, will provide an unprecedented opportunity to
interrogate the early molecular mechanisms thereof and translate
these findings to humans.
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